Literature DB >> 19342651

Statins impair CD1d-mediated antigen presentation through the inhibition of prenylation.

Masood A Khan1, Richard M Gallo, Gourapura J Renukaradhya, Wenjun Du, Jacquelyn Gervay-Hague, Randy R Brutkiewicz.   

Abstract

Statins are widely used as cholesterol-lowering agents that also decrease inflammation and target enzymes essential for prenylation, an important process in the activation and intracellular transport of proteins vital for a wide variety of cellular functions. Here, we report that statins impair a critical component of the innate immune response, CD1d-mediated Ag presentation. The addition of specific intermediates in the isoprenylation pathway reversed this effect, whereas specific targeting of enzymes responsible for prenylation mimicked the inhibitory effects of statins on Ag presentation by CD1d as well as MHC class II molecules. This study demonstrates the importance of isoprenylation in the regulation of Ag presentation and suggests a mechanism by which statins reduce inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342651      PMCID: PMC2850571          DOI: 10.4049/jimmunol.0804311

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

Review 1.  Mechanisms of plaque stabilization with statins.

Authors:  Peter Libby; Masanori Aikawa
Journal:  Am J Cardiol       Date:  2003-02-20       Impact factor: 2.778

2.  Statins inhibit human APC function: implications for the treatment of GVHD.

Authors:  Alexander Shimabukuro-Vornhagen; Tanja Liebig; Michael von Bergwelt-Baildon
Journal:  Blood       Date:  2008-08-15       Impact factor: 22.113

Review 3.  New insights into the pharmacodynamic and pharmacokinetic properties of statins.

Authors:  A Corsini; S Bellosta; R Baetta; R Fumagalli; R Paoletti; F Bernini
Journal:  Pharmacol Ther       Date:  1999-12       Impact factor: 12.310

4.  Expression of heat shock protein-70 by dendritic cells in the arterial intima and its potential significance in atherogenesis.

Authors:  Yuri V Bobryshev; Reginald S A Lord
Journal:  J Vasc Surg       Date:  2002-02       Impact factor: 4.268

5.  Recycling CD1d1 molecules present endogenous antigens processed in an endocytic compartment to NKT cells.

Authors:  Tonya J Roberts; Venkataraman Sriram; Philip M Spence; Ming Gui; Kyoko Hayakawa; Igor Bacik; Jack R Bennink; Jonathan W Yewdell; Randy R Brutkiewicz
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

6.  Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.

Authors:  Keshab Chandra Roy; Igor Maricic; Archana Khurana; Trevor R F Smith; Ramesh C Halder; Vipin Kumar
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

7.  The double-edged sword of statin immunomodulation.

Authors:  Mark R Goldstein; Luca Mascitelli; Francesca Pezzetta
Journal:  Int J Cardiol       Date:  2008-05-16       Impact factor: 4.164

Review 8.  NKT cell subsets in infection and inflammation.

Authors:  Woon Ling Chan; Nada Pejnovic; Tze Vun Liew; Christine A Lee; Richard Groves; Hamish Hamilton
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

9.  Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells.

Authors:  Venkataraman Sriram; Sungyoo Cho; Ping Li; Patrick W O'Donnell; Claire Dunn; Kyoko Hayakawa; Janice S Blum; Randy R Brutkiewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

10.  Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice.

Authors:  Leah Rogers; Sarah Burchat; Jessica Gage; Mirela Hasu; Mohamad Thabet; Lindsay Willcox; Lindsay Wilcox; Tanya A Ramsamy; Stewart C Whitman
Journal:  Cardiovasc Res       Date:  2008-01-10       Impact factor: 10.787

View more
  7 in total

1.  Inhibition of CD1d-mediated antigen presentation by the transforming growth factor-β/Smad signalling pathway.

Authors:  Jennifer C Bailey; Abhirami K Iyer; Gourapura J Renukaradhya; Yinling Lin; Hoa Nguyen; Randy R Brutkiewicz
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

2.  Anthrax lethal toxin impairs CD1d-mediated antigen presentation by targeting the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway.

Authors:  Masood A Khan; Richard M Gallo; Randy R Brutkiewicz
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

3.  Regulation of the actin cytoskeleton by Rho kinase controls antigen presentation by CD1d.

Authors:  Richard M Gallo; Masood A Khan; Jianjian Shi; Reuben Kapur; Lei Wei; Jennifer C Bailey; Jianyun Liu; Randy R Brutkiewicz
Journal:  J Immunol       Date:  2012-07-13       Impact factor: 5.422

Review 4.  The cholesterol pathway: impact on immunity and cancer.

Authors:  Ryan J King; Pankaj K Singh; Kamiya Mehla
Journal:  Trends Immunol       Date:  2022-01       Impact factor: 16.687

5.  Forming a complex with MHC class I molecules interferes with mouse CD1d functional expression.

Authors:  Renukaradhya J Gourapura; Masood A Khan; Richard M Gallo; Daniel Shaji; Jianyun Liu; Randy R Brutkiewicz
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

6.  Therapeutic Effect of Bilsaan, Sambucus nigra Stem Exudate, on the OVA-Induced Allergic Asthma in Mice.

Authors:  Faris Alrumaihi; Ahmad Almatroudi; Khaled S Allemailem; Arshad H Rahmani; Arif Khan; Masood Alam Khan
Journal:  Oxid Med Cell Longev       Date:  2020-06-14       Impact factor: 6.543

Review 7.  Immune mechanisms in atherosclerosis, especially in diabetes type 2.

Authors:  Johan Frostegård
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-29       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.